IWB

One of the most important principles of sound investment management is staying on top of what’s happening in the world and how those events affect finances. Conditions change quickly, and keeping up-to-date on developments and trends can be challenging. The team of experts producing IWB have been advising Canadian investors for over 25 years.

Edited and Published by Gordon Pape. Associate Editor: Richard Croft

With Gavin Graham, Ryan Irvine, Glenn Rogers, Shawn Allen, Adam Mayers, Paul Bamford & Michael Corcoran.

Recent Issues

Recent Updates

BCE Inc. (TSX, NYSE: BCE)

BCE is Canada’s largest communications company, providing a comprehensive suite of broadband, mobile, landline, and cable communication services to residential and business customers through Bell Canada and Bell Aliant. Bell Media is the company’s multimedia arm, with assets in television, radio, and digital media. Television assets include the CTV television network and many of the country’s most-watched specialty channels.


Hold

Updated August 26



Nutrien Corp. (TSX, NYSE: NTR)

Nutrien is the world’s largest producer of agricultural fertilizers. This includes nitrogen and phosphates, which it sells in bulk and at the retail level to farmers.


Buy

Updated August 26



iShares Edge MSCI Minimum Volatility USA Index ETF (CAD-Hedged) (TSX: XMS)

XMS invests in low-beta U.S. stocks such as Coca-Cola, Visa, McDonalds, and Verizon. Low beta means they are less sensitive to broad market movements and, in theory, less risky.


Buy

Updated August 26



CGI Group (TSX: GIB.A, NYSE: GIB)

CGI is the fifth largest independent information technology and business process services firm in the world. It employs about 74,000 professionals in offices and delivery centres across the Americas, Europe, and the Asia Pacific region. The company offers a range of services including high-end business and IT consulting, systems integration, application development and maintenance, infrastructure management, as well as many proprietary solutions.


Buy

Updated August 26



Eli Lilly & Co. (NYSE: LLY)

Eli Lilly is one of the world’s largest pharmaceutical companies. It is a leading producer of a new type of diabetes/weight loss drug. Eli Lilly’s trade name for their drug is Mounjaro. It was approved in the US in 2022 for treatment of Type 2 diabetes and is expected to be approved as a weight-loss drug by year-end.


Buy

Updated August 26